Jeremy D. Gates - Concepedia

Author

Jeremy D. Gates

Brooke Army Medical Center

Also Known As

J. D. Gates, J. Gates, J.D. Gates, Jeremy D Gates, Jeremy D. Gates

Publications

911

Citations

H-Index

Concepts

All Affiliations

Brooke Army Medical Center Uniformed Services University of the Health Sciences Walter Reed Army Institute of Research Naval Medical Center San Diego Joint Base San Antonio

About

Jeremy D. Gates is an author at Brooke Army Medical Center specializing in vaccination, immunotherapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	63
2	Immunology	2	2	63
3	Engineering	1	1	28
4	Health Sciences	1	1	28
5	Autoimmunity	1	1	37

Jeremy D. Gates

Publications

833

Citations

H-Index

Page 1

	Year	Citations
Clinical trial results of the HER‐2/<i>neu</i> (E75) vaccine to prevent breast cancer recurrence in high‐risk patients Elizabeth A. Mittendorf, Guy T. Clifton, Jarrod P. Holmes, Cancer	2011	170
Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/<i>neu</i>Peptide (AE37) Vaccine Jarrod P. Holmes, Linda C. Benavides, Jeremy D. Gates, Journal of Clinical Oncology	2008	136
The Impact of HER2/<i>neu</i>Expression Level on Response to the E75 Vaccine: From U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02 Linda C. Benavides, Jeremy D. Gates, Mark G. Carmichael, Clinical Cancer Research	2009	116
Results of the first phase 1 clinical trial of the HER‐2/<i>neu</i> peptide (GP2) vaccine in disease‐free breast cancer patients Mark G. Carmichael, Linda C. Benavides, Jarrod P. Holmes, Cancer	2009	100
Optimal dose and schedule of an HER‐2/<i>neu</i> (E75) peptide vaccine to prevent breast cancer recurrence Jarrod P. Holmes, Jeremy D. Gates, Linda C. Benavides, Cancer	2008	50
Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/ neu -Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial Ritesh Patil, Guy T. Clifton, Jarrod P. Holmes, Journal of the American College of Surgeons	2009	49
Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine Jarrod P. Holmes, Guy T. Clifton, Ritesh Patil, Cancer	2010	48
Preoperative Thyroid Ultrasound Is Indicated in Patients Undergoing Parathyroidectomy for Primary Hyperparathyroidism Cletus A. Arciero, Zita Shiue, Jeremy D. Gates, Journal of Cancer	2012	40
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide Jeremy D. Gates, Guy T. Clifton, Linda C. Benavides, Vaccine VaccinationCancer ImmunosurveillanceBreast Cancer PatientsT-regulatory CellImmunology	2010	37
Preoperative Thyroid Ultrasound In All Patients Undergoing Parathyroidectomy? Jeremy D. Gates, Linda C. Benavides, Craig D. Shriver, Journal of Surgical Research EngineeringMedical ImagingThyroid DiseasePreoperative Thyroid UltrasoundParathyroid Disease	2008	28

Page 1